Liver disease

There are 427 papers on liver disease in aging research: 8 trials and 243 observational studies in people, 30 in animals, 1 in cells, 137 reviews. The newest story, Nov 18, 2026: “Death risks linked to fatty liver varied by disease type”.

Disease

427 papers study it3,053 more mention it67 findings

MeSH

298 new papers in 30 daysSee all 3,480 papers on liver disease

At a glance

Liver disease is linked with shorter lifespan in men and higher in-hospital mortality in hospitalized older adults. Human cohorts associate biological age and frailty–depression trajectories with liver disease; reviews link liver aging and cellular senescence to disease. Deleterious TERT variants are associated with liver disease in UK Biobank but show no clear link in DiscovEHR.

67 findings in 62 papers from 2016 to 2026, 10 of them since June 2026

“and liver diseases (OR = 3.0 (1.5-5.9, 95% CI)).”
Insights into DNA repeat expansions among 900,000 biobank participantsNature2026doi:10.1038/s41586-025-09886-z
  • Human trial8
  • Humans243
  • Animals30
  • Cells1
  • In silico6

Interventions

2

Beta-hydroxybutyrate

downin reviews1

1 study
  1. Beta-hydroxybutyrate protects against liver disease.

    “we summarize the therapeutic effects of β-HB on liver diseases”

    Review

    β-hydroxybutyrate: A crucial therapeutic target for diverse liver diseases

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

More on Beta-hydroxybutyrate

Nutritional interventions

downin humans1

1 study
  1. Nutritional interventions decrease liver disease in humans.

    “Nutritional and pharmacological interventions can improve liver disorders, and nutritional interventions are less risky relatively”

    Reviewliver

    Aging Liver: Can Exercise be a Better Way to Delay the Process than Nutritional and Pharmacological Intervention? Focus on Lipid Metabolism

    Current pharmaceutical design

More on Nutritional interventions

Effects

2

Total brain volume

downin humans1

1 study
  1. Liver disease is linked with lower total brain volume in humans.

    “liver disease was associated with accelerated decline in total brain and white matter volume”

    Humansbrain

    Association of liver disease with brain volume loss, cognitive decline, and plasma neurodegenerative disease biomarkers

    Neurobiology of aging

Lifespan

downin humans1

1 study
  1. Liver disease is linked with shorter lifespan in humans (1.22 years).

    “The life expectancy disadvantage among Native American males was primarily attributable to motor vehicle accidents (0.96 years), liver disease (1.22 years), and diabetes (0.78 years).”

    Humansmales

    Contributors to reduced life expectancy among Native Americans in the Four Corners States

    PloS one

Upstream

7

Frailty index

mediatesin humans1

1 study
  1. Frailty index is linked with liver disease in humans (joint BMI-depressive symptom trajectories and incident liver disease) (8.5%-15.3% (China) and 6.8%-12.7% (Korea)).

    “Frailty index mediated 8.5%-15.3% of these associations in the Chinese cohort and 6.8%-12.7% in the Korean cohort.”

    Humansjoint BMI-depressive symptom trajectories and incident liver diseasen = 17,582

    Joint trajectories of body mass index and depressive symptoms and incident liver disease: A multicohort study with frailty mediation analysis

    Maturitas

More on Frailty index

Mutant hepatocytes

downin humans1

1 study
  1. mutant hepatocytes protect against liver disease in humans.

    “mutant hepatocytes can protect against liver disease”

    Reviewliver

    Somatic genomics as a discovery engine for biomedicine

    Cell

Biological age

mediatesin humans1

1 study
  1. Biological age is linked with liver disease in humans (air pollution-associated liver diseases) (1.9% to 7.7%).

    “Furthermore, the mediated proportion of accelerated biological aging was 1.9% to 7.7% for air pollution-associated liver diseases.”

    Humansair pollution-associated liver diseases13.57 yearsn = 418,576

    Combined effects of ambient air pollution exposure and biological aging on incident liver diseases: a large prospective cohort study

    American journal of epidemiology

More on Biological age

SIRT1

downin reviews1

1 study
  1. SIRT1 protects against liver disease.

    “SIRT1 preserves liver function by regulating essential aging-related pathways, including telomere maintenance, epigenetic modifications, cellular senescence, intercellular communication, inflammation, and mitochondrial function.”

    Reviewliver

    Involvement of SIRT1-mediated aging in liver diseases

    Frontiers in cell and developmental biology

More on SIRT1

GDF11

downin reviews1

1 study
  1. GDF11 protects against liver disease.

    “much of the literature indicates that GDF11 displays effects tending to solve or mitigate pathological states of the liver”

    Reviewliver

    The hepatic effects of GDF11 on health and disease

    Biochimie

More on GDF11

EGLN1

downin mice1

1 study
  1. EGLN1 decreases liver disease in mice (shown by genetic deficiency).

    “the HIF-P4H-2-deficient mice having less inflammation, liver diseases, including cancer, and myocardial infarctions, and not developing anemia.”

    Animalsshown by genetic deficiency

    Systemic long-term inactivation of hypoxia-inducible factor prolyl 4-hydroxylase 2 ameliorates aging-induced changes in mice without affecting their life span

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology

More on EGLN1

chronic liver inflammation

upin humans1

1 study
  1. chronic liver inflammation increases liver disease in humans.

    “chronic liver inflammation has all the major characteristics of "inflammaging" and likely sustains the onset and progression of liver diseases”

    Reviewliver

    The peculiar aging of human liver: A geroscience perspective within transplant context

    Ageing research reviews

Associations

44

Mortality

upin humans7HR 1.69–3.007

7 studies
  1. Liver disease is linked with a higher risk of mortality in humans (undergoing primary total hip arthroplasty) (HR = 1.69; 95% CI = 1.25-2.27).

    “liver disease (HR = 1.69; 95% CI = 1.25-2.27)”

    Humansundergoing primary total hip arthroplasty

    Perioperative risk factor analysis for mortality in patients undergoing total hip arthroplasty: A national database study from Türkiye

    Acta orthopaedica et traumatologica turcica

  2. Liver disease predicts mortality in PE cases (aHR 2.17 (95% CI 1.88-2.51)).

    “Predictors of long-term mortality included heart failure (aHR 1.97, 95% CI, 1.88-2.06) and liver disease (aHR 2.17, 95% CI 1.88-2.51)”

    Humansin PE cases

    Long-term mortality in patients with first-time pulmonary embolism according to the presence of comorbidities at baseline: a nationwide register study

    European journal of internal medicine

  3. Liver disease is linked with a higher risk of mortality in humans (colorectal cancer) (SHR 1.65 (1.38-1.98)).

    “only dementia [SHR = 1.43 (1.24-1.64)], Peptic ulcer disease [SHR = 1.12 (1.02-1.24)], kidney disease [SHR = 1.11 (1.04-1.20)] and liver disease [SHR = 1.65 (1.38-1.98)] were risk factors for CRC-specific mortality”

    Humanscolorectal cancer

    Associations of advanced age with comorbidity, stage and primary subsite as contributors to mortality from colorectal cancer

    Frontiers in public health

  4. Liver disease is linked with a higher risk of mortality in humans (regardless of age group).

    “Regardless of age group, the presence of neurological disease, renal disease, liver disease, and cancer was associated with an increased risk of mortality.”

    Humansregardless of age group

    Comorbidities associated with COVID-19 mortality in adults in Lima, Peru: a retrospective cohort study

    Revista peruana de medicina experimental y salud publica

  5. Liver disease is associated with mortality in humans (post-FME patients) (HR 1.81, 95% CI 1.18-2.78).

    “hepatic disease (HR 1.81, 95% CI 1.18-2.78)”

    Humanspost-FME patients

    What Happens to Full Mouth Extraction Patients? A Retrospective Review of Patient Mortality at an Academic Medical Center

    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons

  6. Liver disease is associated with mortality in humans (Renal cell carcinoma) (HR 2.09, 95% CI 1.53-2.84; HR 4.01, 95% CI 2.44-6.56).

    “Particularly, diagnoses of liver disease (HR 2.09, 95% CI 1.53-2.84 and HR 4.01, 95% CI 2.44-6.56) and dementia (HR 2.16, 95% CI 1.34-3.48) increased mortality.”

    HumansRenal cell carcinoma

    Impact of comorbidity on renal cell carcinoma prognosis: a nationwide cohort study

    Acta oncologica (Stockholm, Sweden)

  7. Liver disease is linked with a higher risk of mortality in humans (symptomatic severe aortic stenosis undergoing TAVI) (HR 3.007, 95% CI 1.067-8.477).

    “presence of liver disease (HR, 3.007; CI, 1.067-8.477; p=0.04) were independently associated with 3-year all-cause mortality”

    Humanssymptomatic severe aortic stenosis undergoing TAVI3 yearsn = 280

    Kihon checklist is useful for predicting outcomes in patients undergoing transcatheter aortic valve implantation

    Journal of cardiology

Cellular senescence

upin reviews2upin humans1mixedin reviews1

4 studies
  1. Cellular senescence is associated with liver disease in humans.

    “Robust clinical evidence has now demonstrated a strong correlation between cellular senescence and poor clinical outcomes in various hepatopathies.”

    Review

    Role of cellular senescence in hepatic diseases (Review)

    International journal of molecular medicine

  2. Cellular senescence raises the risk of liver disease.

    “cholangiocyte senescence/SASP is proposed to be a driver of disease phenotypes in a variety of liver injuries”

    Reviewliver

    Biliary Epithelial Senescence in Liver Disease: There Will Be SASP

    Frontiers in molecular biosciences

  3. Cellular senescence is associated with liver disease.

    “cellular senescence plays a relevant role in the occurrence and development of liver disease”

    Reviewliver

    Cellular Senescence in Liver Disease and Regeneration

    Seminars in liver disease

  4. Cellular senescence is associated with liver disease.

    “accumulating evidence shows that cellular senescence is closely related to various liver diseases.”

    Review

    Cellular senescence and liver disease: Mechanisms and therapeutic strategies

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

More on Cellular senescence

Cardiovascular disease

upin humans2OR 1.49–1.6

2 studies
  1. Liver disease is linked with a higher risk of cardiovascular disease in humans (multivariable analysis) (adjusted OR 1.60).

    “liver disease (adjusted OR 1.60) as principal independent predictors”

    Humansmultivariable analysis9 yearsn = 5,657

    Explainable machine learning for long-term cardiovascular disease risk prediction in Chinese middle-aged and older adults: a 9-year longitudinal cohort study with web-based risk calculator

    Scientific reports

  2. Cardiovascular disease is associated with liver disease in humans (OR = 1.49).

    “significant associations between CVD and chronic lung disease (OR = 1.78), liver disease (OR = 1.49), and kidney disease (OR = 1.85).”

    Humans

    Epidemiological trends, risk factor contributions, and future projections of cardiovascular disease among Chinese adults ≥45 years: insights from GBD 2021 and CHARLS

    Experimental gerontology

More on Cardiovascular disease

C-reactive protein-triglyceride-glucose index

upin humans2HR 1.21

2 studies
  1. C-reactive protein-triglyceride-glucose index is linked with a higher risk of liver disease in humans (HR 1.210, 95% CI 1.109-1.321).

    “each 1-unit increment in CTI was significantly associated with a 21.0% increased risk of liver disease (Hazard Ratio [HR] = 1.210, 95% Confidence Interval [CI]: 1.109-1.321).”

    Humans

    The C-reactive Protein-Triglyceride-Glucose Index in Relation to Liver Disease

    Inquiry : a journal of medical care organization, provision and financing

  2. C-reactive protein-triglyceride-glucose index is associated with liver disease in humans (OR 1.279, 95% CI 1.124–1.455).

    “liver disease (OR = 1.279, 95% CI: 1.124, 1.455)”

    Humans2011–2020n = 9,275

    The Role of the C-Reactive Protein-Triglyceride Glucose Index in Predicting New-Onset Chronic Diseases: Evidence From a Longitudinal Cohort Study

    Brain and behavior

More on C-reactive protein-triglyceride-glucose index

GLS

upin humans2OR 3

2 studies
  1. GLS is associated with liver disease in humans (Expanded repeats in the GLS 5' untranslated region) (OR 3.0, 95% CI 1.5–5.9).

    “and liver diseases (OR = 3.0 (1.5-5.9, 95% CI)).”

    HumansExpanded repeats in the GLS 5' untranslated region

    Insights into DNA repeat expansions among 900,000 biobank participants

    Nature

  2. GLS is associated with liver disease in humans (OR=3.0 [1.5-5.9]).

    “inherited repeats in the 5' UTR of the glutaminase ( GLS) gene are associated with stage 5 chronic kidney disease (OR=14.0 [5.7-34.3]) and liver diseases (OR=3.0 [1.5-5.9])”

    Humansblood

    Insights into the causes and consequences of DNA repeat expansions from 700,000 biobank participants

    bioRxiv : the preprint server for biologyPreprint

More on GLS

TERT

upin humans1OR 2.4

1 study
  1. TERT is associated with liver disease in humans (Deleterious TERT variants in UK Biobank; association not observed in DiscovEHR) (OR 2.4, 95% CI 1.25–4.59).

    “Deleterious TERT variants were also associated with higher risk of LD”

    HumansDeleterious TERT variants in UK Biobank; association not observed in DiscovEHR

    Harmful inherited gene changes linked to lung scarring

    PLoS genetics

More on TERT

HDL-C

upin humans1+41%

1 study
  1. HDL-C is associated with liver disease in humans (Extremely low HDL-C (<20 mg/dL)) (41.2%).

    “Extremely low HDL-C was more frequently associated with liver disease (41.2%) and active malignancy (29.4%)”

    HumansExtremely low HDL-C (<20 mg/dL)

    Prevalence, clinical characteristics, and etiologic spectrum of extremely low levels of high-density lipoprotein cholesterol in Thai patients: a single-center study

    Annals of medicine

More on HDL-C

Normal Weight-High Depression

upin humans1HR 2.45

1 study
  1. Normal Weight-High Depression is linked with a higher risk of liver disease in the Chinese cohort (CHARLS) (HR 2.45, 95% CI 1.80-3.35).

    “Normal Weight-High Depression was associated with hazard ratios of 2.45 (95% confidence interval 1.80-3.35; p < 0.001)”

    Humansin the Chinese cohort (CHARLS)n = 10,487

    Joint trajectories of body mass index and depressive symptoms and incident liver disease: A multicohort study with frailty mediation analysis

    Maturitas

Obese-Moderate Depression

upin humans1HR 3.53

1 study
  1. Obese-Moderate Depression is linked with a higher risk of liver disease in the Chinese cohort (CHARLS) (HR 3.53, 95% CI 2.59-4.79).

    “hazard ratios for Obese-Moderate Depression were 3.53 (95% confidence interval 2.59-4.79; p < 0.001) in the Chinese cohort”

    Humansin the Chinese cohort (CHARLS)n = 10,487

    Joint trajectories of body mass index and depressive symptoms and incident liver disease: A multicohort study with frailty mediation analysis

    Maturitas

MASLD polygenic subtypes

upin humans1

1 study
  1. MASLD polygenic subtypes are linked with a higher risk of liver disease in humans.

    “All three subtypes consistently increased liver disease risk”

    Humanslivern = 427,030

    Multi-omics dissection of MASLD reveals divergent pathways to systemic diseases and targets for prevention

    Metabolism: clinical and experimental

All 44

Trial sponsors

Funding

83 grants since 2016

National Institute of Diabetes and Digestive and Kidney Diseases$28.5MJapan Society for the Promotion of Science¥67.9MNational Institute on Alcohol Abuse and Alcoholism$2.1M

Contains public sector information licensed under the Open Government Licence v3.0.

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    A Chinese human cohort associates normal-weight/high-depression and obese/moderate-depression profiles with greater liver disease risk. Frailty partly mediates associations between BMI–depressive symptom trajectories and incident liver disease in Chinese and Korean cohorts; microbiome composition predicts liver disease in a separate human study.

  2. Summary written from the findings.

Latest

Nature Metabolism

Blood protein model better predicts future diabetes risk

In about 20,000 UK Biobank participants, the model scored 0.86 for ranking diabetes risk, versus 0.74 for a blood-fat ratio.In about 20,000 UK Biobank participants, the model scored 0.86 for ranking diabetes risk, versus 0.74 for a blood-fat ratio.

Cohort · 20,612 peopleType 2 diabetes
Diabetology & Metabolic Syndrome

Death risks linked to fatty liver varied by disease type

The relative risk of death from heart and blood vessel diseases was higher with fatty liver disease than without it, with a hazard ratio of 1.57.The relative risk of death from heart and blood vessel diseases was higher with fatty liver disease than without it, with a hazard ratio of 1.57.

Cohort · 486,156 peoplePopulations

See all 3,480 papers on liver disease